A researcher in the University of Cincinnati (UC) College of Medicine has been granted a U.S. patent for a potential treatment for a pulmonary infection in patients with cystic fibrosis (CF) and chronic obstructive pulmonary ...
Mar 27, 2018
0
13
Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to ...
Feb 5, 2018
0
82
Idiopathic pulmonary fibrosis is a potentially lethal disease associated with the presence of critically short telomeres, currently lacking effective treatment. The Telomere and Telomerase Group at the Spanish National Cancer ...
Jan 30, 2018
0
57
Obstructive pulmonary disease is a collective term for refractory respiratory diseases with chronic airway inflammation and excessive mucus retention that are accompanied by airway obstruction. They include chronic obstructive ...
Dec 29, 2017
0
16
To date, the molecular basis of pulmonary fibrosis has been poorly understood. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now shown that reduced activity of the transcription ...
Dec 26, 2017
0
91
Thyroid hormone therapy significantly resolves fibrosis, or scarring, in the lungs of mice, increasing their survival from disease, a Yale-led study shows. These provide a novel insight into the development of pulmonary fibrosis ...
Dec 4, 2017
0
327
A drug used to thin blood has been found to also significantly improve the ability to breathe when inhaled by people with COPD (chronic obstructive pulmonary disease), for which there is no cure.
Dec 1, 2017
0
126
A study led by investigators at Massachusetts General Hospital (MGH) and University Health Network (UHN) in Toronto has identified a molecular pathway that appears to be critical to the development of fibrosis - scarring ...
Nov 15, 2017
0
58
Health scientists at the University of Leicester and University of Nottingham have heralded the discovery of a gene associated with lung fibrosis as 'a potential new avenue of treatment for further research into this terrible ...
Oct 23, 2017
0
1
(HealthDay)—The six-minute walk test (6MWT) is increasingly being used for patients with idiopathic pulmonary fibrosis (IPF), and guidelines are needed for its implementation in this population, according to a report published ...
Oct 13, 2017
0
0
